Necessity of antibacterial prophylaxis in the treatment of reno-ureteral lithiasis by extracorporeal shock wave lithotripsy. A prospective descriptive study
Închide
Conţinutul numărului revistei
Articolul precedent
Articolul urmator
425 0
Căutarea după subiecte
similare conform CZU
616.613-003.7-07-08 (4)
Patologia sistemului urogenital. Boli urinare şi sexuale (genitale) (368)
SM ISO690:2012
BRADU, Andrei, CEBAN, Emil. Necessity of antibacterial prophylaxis in the treatment of reno-ureteral lithiasis by extracorporeal shock wave lithotripsy. A prospective descriptive study. In: Archives of the Balkan Medical Union, 2020, nr. 2(55), pp. 264-268. ISSN 1584-9244. DOI: https://doi.org/10.31688/ABMU.2020.55.2.08
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
Archives of the Balkan Medical Union
Numărul 2(55) / 2020 / ISSN 1584-9244

Necessity of antibacterial prophylaxis in the treatment of reno-ureteral lithiasis by extracorporeal shock wave lithotripsy. A prospective descriptive study

DOI: https://doi.org/10.31688/ABMU.2020.55.2.08
CZU: 616.613-003.7-07-08

Pag. 264-268

Bradu Andrei, Ceban Emil
 
”Nicolae Testemițanu” State University of Medicine and Pharmacy
 
Disponibil în IBN: 8 octombrie 2020


Rezumat

Introduction. Due to the increase in the incidence of reno-ureteral lithiasis worldwide from 1% to 15%, varying according to age, sex, race, and geographical location, extracorporeal shock wave lithotripsy remains the method of choice in the treatment of reno-ureteral lithiasis. The need for antibacterial prophylaxis is required only in well-defined cases, uroculture with antibacterial sensitivity being crucial in order to reduce the infectious complications. The objective of the study was to evaluate the need for antibiotic administration and to detect risk factors for the development of post-ESWL bacteriuria. Material and methods. Between 05 Nov 2018 – 10 Dec 2019, a group of 120 patients with the diagnosis of reno-ureteral lithiasis was selected, who underwent ESWL treatment in Department of Urology and Surgical Nephrology from Republican Clinical Hospital „Timofei Mosneaga“. In all 120 patients, urine sample was taken before and after ESWL. In all patients included in the study, uroculture with antibiogram was performed.Results. The uroculture results obtained before ESWL were positive in 25 (20.84%) patients without any clinical symptoms and absence of leukocytes in the general urine analysis more than 10 per high power field. At the same time, the number of positive urine culture after ESWL increased significantly in 47 patients. Conclusions. Antibiotic prophylaxis is not justified in the absence of definite risk factors such as positive urine culture before ESWL, JJ stent or nephrostome and a history of infectious reno-ureteral lithiasis or recurrent urinary tract infections. Copyright

Cuvinte-cheie
antibacterial therapy, ESWL, Reno-ureteral lithiasis

Cerif XML Export

<?xml version='1.0' encoding='utf-8'?>
<CERIF xmlns='urn:xmlns:org:eurocris:cerif-1.5-1' xsi:schemaLocation='urn:xmlns:org:eurocris:cerif-1.5-1 http://www.eurocris.org/Uploads/Web%20pages/CERIF-1.5/CERIF_1.5_1.xsd' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' release='1.5' date='2012-10-07' sourceDatabase='Output Profile'>
<cfResPubl>
<cfResPublId>ibn-ResPubl-111453</cfResPublId>
<cfResPublDate>2020-06-01</cfResPublDate>
<cfVol>55</cfVol>
<cfIssue>2</cfIssue>
<cfStartPage>264</cfStartPage>
<cfISSN>1584-9244</cfISSN>
<cfURI>https://ibn.idsi.md/ro/vizualizare_articol/111453</cfURI>
<cfTitle cfLangCode='EN' cfTrans='o'>Necessity of antibacterial prophylaxis in the treatment of reno-ureteral lithiasis by extracorporeal shock wave lithotripsy. A prospective descriptive study</cfTitle>
<cfKeyw cfLangCode='EN' cfTrans='o'>antibacterial therapy; ESWL; Reno-ureteral lithiasis</cfKeyw>
<cfAbstr cfLangCode='EN' cfTrans='o'><p>Introduction. Due to the increase in the incidence of reno-ureteral lithiasis worldwide from 1% to 15%, varying according to age, sex, race, and geographical location, extracorporeal shock wave lithotripsy remains the method of choice in the treatment of reno-ureteral lithiasis. The need for antibacterial prophylaxis is required only in well-defined cases, uroculture with antibacterial sensitivity being crucial in order to reduce the infectious complications. The objective of the study was to evaluate the need for antibiotic administration and to detect risk factors for the development of post-ESWL bacteriuria. Material and methods. Between 05 Nov 2018 &ndash; 10 Dec 2019, a group of 120 patients with the diagnosis of reno-ureteral lithiasis was selected, who underwent ESWL treatment in Department of Urology and Surgical Nephrology from Republican Clinical Hospital &bdquo;Timofei Mosneaga&ldquo;. In all 120 patients, urine sample was taken before and after ESWL. In all patients included in the study, uroculture with antibiogram was performed.</p><p>Results. The uroculture results obtained before ESWL were positive in 25 (20.84%) patients without any clinical symptoms and absence of leukocytes in the general urine analysis more than 10 per high power field. At the same time, the number of positive urine culture after ESWL increased significantly in 47 patients. Conclusions. Antibiotic prophylaxis is not justified in the absence of definite risk factors such as positive urine culture before ESWL, JJ stent or nephrostome and a history of infectious reno-ureteral lithiasis or recurrent urinary tract infections. Copyright</p></cfAbstr>
<cfResPubl_Class>
<cfClassId>eda2d9e9-34c5-11e1-b86c-0800200c9a66</cfClassId>
<cfClassSchemeId>759af938-34ae-11e1-b86c-0800200c9a66</cfClassSchemeId>
<cfStartDate>2020-06-01T24:00:00</cfStartDate>
</cfResPubl_Class>
<cfResPubl_Class>
<cfClassId>e601872f-4b7e-4d88-929f-7df027b226c9</cfClassId>
<cfClassSchemeId>40e90e2f-446d-460a-98e5-5dce57550c48</cfClassSchemeId>
<cfStartDate>2020-06-01T24:00:00</cfStartDate>
</cfResPubl_Class>
<cfPers_ResPubl>
<cfPersId>ibn-person-29881</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2020-06-01T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-10919</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2020-06-01T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfFedId>
<cfFedIdId>ibn-doi-111453</cfFedIdId>
<cfFedId>10.31688/ABMU.2020.55.2.08</cfFedId>
<cfStartDate>2020-06-01T24:00:00</cfStartDate>
<cfFedId_Class>
<cfClassId>31d222b4-11e0-434b-b5ae-088119c51189</cfClassId>
<cfClassSchemeId>bccb3266-689d-4740-a039-c96594b4d916</cfClassSchemeId>
</cfFedId_Class>
<cfFedId_Srv>
<cfSrvId>5123451</cfSrvId>
<cfClassId>eda2b2e2-34c5-11e1-b86c-0800200c9a66</cfClassId>
<cfClassSchemeId>5a270628-f593-4ff4-a44a-95660c76e182</cfClassSchemeId>
</cfFedId_Srv>
</cfFedId>
</cfResPubl>
<cfPers>
<cfPersId>ibn-Pers-29881</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-29881-3</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2020-06-01T24:00:00</cfStartDate>
<cfFamilyNames>Bradu</cfFamilyNames>
<cfFirstNames>Andrei</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-10919</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-10919-3</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2020-06-01T24:00:00</cfStartDate>
<cfFamilyNames>Ceban</cfFamilyNames>
<cfFirstNames>Emil</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfSrv>
<cfSrvId>5123451</cfSrvId>
<cfName cfLangCode='en' cfTrans='o'>CrossRef DOI prefix service</cfName>
<cfDescr cfLangCode='en' cfTrans='o'>The service of issuing DOI prefixes to publishers</cfDescr>
<cfKeyw cfLangCode='en' cfTrans='o'>persistent identifier; Digital Object Identifier</cfKeyw>
</cfSrv>
</CERIF>